The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| NATERA, INC. | COM | 632307104 | 2,998 | 32,098 | SH | SOLE | 0 | 0 | 32,098 | ||
| PULMATRIX, INC. | COM | 74584P202 | 19 | 43,639 | SH | SOLE | 0 | 0 | 43,639 | ||
| ZYMERGEN INC. | COM | 98985X100 | 797 | 119,205 | SH | SOLE | 0 | 0 | 119,205 | ||
| KARUNA THERAPEUTICS, INC. | COM | 48576A100 | 381,586 | 2,912,872 | SH | SOLE | 0 | 0 | 2,912,872 | ||
| RUBIUS THERAPEUTICS, INC. | COM | 78116T103 | 3,387 | 349,908 | SH | SOLE | 0 | 0 | 349,908 | ||
| SINGULAR GENOMICS SYSTEMS, INC. | COM | 82933R100 | 43,916 | 3,798,926 | SH | SOLE | 0 | 0 | 3,798,926 | ||
| EQRX, INC. | COM | 26886C107 | 247,807 | 36,335,375 | SH | SOLE | 0 | 0 | 36,335,375 | ||
| ERASCA, INC. | COM | 29479A108 | 172,246 | 11,055,554 | SH | SOLE | 0 | 0 | 11,055,554 | ||
| VERVE THERAPEUTICS, INC. | COM | 92539P101 | 92,500 | 2,508,809 | SH | SOLE | 0 | 0 | 2,508,809 | ||